Beth Israel Deconess Medical Center

Boston, Massachusetts 02215

0 studies enrolling now · 9 studies all time

What they study most

Acute Lung Injury, Acute Respiratory Distress Syndrome, Chronic Genotype 1a or 1b HCV Infection, Clear Cell Renal Cell Carcinoma, Critical Illness, Depression, Epilepsy, Epilepsy in Children, Epilepsy, Tonic-Clonic, Focal Seizure, Hepatitis C, Chronic, Kidney Cancer

Studies at this site

• Pivotal-Safety and Therapeutic Measures of tDCS in Patients With Refractory Focal Epilepsy — Completed
• Effects of TNX-832 (Sunol cH36) in Subjects With Acute Lung Injury/Acute Respiratory Distress Syndrome — Completed
• Effects of Mobility Dose on Discharge Disposition in Critically Ill Stroke Patients — Completed
• A Phase 1, Dose-Escalation Trial of PT2385 Tablets In Patients With Advanced Clear Cell Renal Cell Carcinoma (MK-3795-001) — Running, not enrolling
• Addition of ISIS 14803 to Therapy With Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) Patients Not Responding Adequately to the Two Drugs — Completed
• NeoMend ProGEL™ Pleural Air Leak Sealant Post-Approval Study — Completed
• A Computerized Intervention for Depression — Completed
• Sofosbuvir With Pegylated Interferon and Ribavirin Hepatitis C Virus (HCV) Genotypes 1,4,5,6 — Completed
• GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection — Completed